- Home
- / Atrys Health
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Atrys Health financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
€3.3
2024-10-29
Market Capitalization
€252.8 M
2024-10-29
Revenue
€212.7 M
FY, 2024
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| EUR | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 7.3M | 14.8M | 31.4M | 121.0M | 187.0M | 231.3M | 212.7M |
| Cost of goods sold | 885.0K | 2.7M | 6.8M | 19.5M | 34.2M | 64.4M | 72.7M |
| Gross profit | 6.5M | 12.5M | 27.6M | 105.6M | 154.1M | 167.9M | 147.1M |
| Gross profit margin, % | 89.0% | 84.2% | 88.0% | 87.2% | 82.4% | 72.6% | 69.1% |
| Operating expense total | 4.7M | 9.4M | 21.5M | 98.7M | 127.0M | 129.4M | 106.3M |
| Depreciation and amortization | 1.3M | 1.9M | 4.2M | 20.8M | 33.3M | 45.1M | 29.0M |
| EBITDA | 1.8M | 3.1M | 6.1M | 6.8M | 27.0M | 38.5M | 39.2M |
| EBITDA margin, % | 24.0% | 21.0% | 19.5% | 5.6% | 14.4% | 16.6% | 18.4% |
| EBIT | 475.0K | 1.2M | 1.9M | (14.0M) | (6.2M) | (6.7M) | 10.2M |
| EBIT margin, % | 6.5% | 8.2% | 6.1% | -11.6% | -3.3% | -2.9% | 4.8% |
| Interest income | 1.0K | 1.0K | 209.0K | ||||
| Interest expense | 621.0K | 1.1M | 2.5M | 10.0M | 15.2M | 33.5M | 23.5M |
| Pre tax profit | 63.0K | 207.0K | (1.3M) | (24.9M) | (24.7M) | (48.8M) | (33.6M) |
| Income tax expense | 52.0K | 311.0K | 706.0K | (1.7M) | (1.2M) | (2.9M) | (1.6M) |
| Net Income | 11.0K | (104.0K) | (2.0M) | (23.2M) | (23.5M) | (45.9M) | (32.0M) |